ATX-304 (100mg) x 60 Tablets
• Composition and format
ATX-304 (100 mg) is a single-component research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 100 mg of ATX-304, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) documents active-component identity, per-tablet content verification, physical characteristics, and relevant excipient information to support reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each production lot is qualified at 99%+ purity by high-performance liquid chromatography, with compound identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
• Intended research use
ATX-304 is evaluated exclusively in controlled in-vitro systems investigating peptide-associated signaling pathways, cellular stress-response mechanisms, and pathway modulation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
ATX-304 is characterized for use as a research tool in analytical and cell-based models examining intracellular signaling dynamics, pathway activation profiles, and peptide-related interaction networks. In controlled in-vitro environments, researchers employ ATX-304 to study concentration-response behavior, time-course signaling changes, and mechanistic pathway interactions relevant to cellular homeostasis. Representative applications include assay development, comparative profiling studies, mechanistic pathway investigations, and signaling-network characterization strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
• Composition and format
ATX-304 (100 mg) is a single-component research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 100 mg of ATX-304, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) documents active-component identity, per-tablet content verification, physical characteristics, and relevant excipient information to support reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each production lot is qualified at 99%+ purity by high-performance liquid chromatography, with compound identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
• Intended research use
ATX-304 is evaluated exclusively in controlled in-vitro systems investigating peptide-associated signaling pathways, cellular stress-response mechanisms, and pathway modulation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
ATX-304 is characterized for use as a research tool in analytical and cell-based models examining intracellular signaling dynamics, pathway activation profiles, and peptide-related interaction networks. In controlled in-vitro environments, researchers employ ATX-304 to study concentration-response behavior, time-course signaling changes, and mechanistic pathway interactions relevant to cellular homeostasis. Representative applications include assay development, comparative profiling studies, mechanistic pathway investigations, and signaling-network characterization strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
